Full metadata record
DC FieldValueLanguage
dc.contributor.authorSong, Yang-
dc.contributor.authorXiao, He-
dc.contributor.authorYang, Zhenzhou-
dc.contributor.authorGeng, Mingying-
dc.contributor.authorMa, Jungang-
dc.contributor.authorRen, Yujiang-
dc.contributor.authorLiu, Yun-
dc.contributor.authorWang, Ge-
dc.date.accessioned2018-02-05T13:23:23Z-
dc.date.available2018-02-05T13:23:23Z-
dc.date.issued2017-11-28-
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/36359-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-18360-
dc.description.abstractThis study was dedicated to investigate the predictive value of pre- and post-induction chemotherapy plasma EBV (Epstein-Barr Virus) DNA level and tumor volume for the radiosensitivity of locally advanced NPC. 129 previously untreated locally advanced NPC patients were enrolled. Plasma EBV-DNA copy number and tumor volume was detected before and after induction chemotherapy. The tumor volume was also measured after radiotherapy. Among 129 patients, 98 were positive for EBV DNA. The residual gross target volume of the primary tumor (GTVnx) and GTVnd after radiotherapy was positively correlated with post-induction chemotherapy EBV copy number (rho=0.357, P<0.001; rho=0.356, P<0.001, respectively). Univariate logistic regression analyses showed that the AUC of ROC curves of post-induction chemotherapy tumor volume, tumor regression rate before and after induction chemotherapy, post-induction EBV copy number, EBV decrease rate for predicting no residual nasopharyngeal tumor were 0.859, 0.782, 0.678 and 0.657, respectively. Multivariate logistic analyses showed that T stage, post-induction chemotherapy EBV copy number and tumor volume were independent predictors for no residual nasopharyngeal tumor after radiotherapy. The changes in plasma EBV DNA and tumor volume during treatment could be used to predict the sensitivity of locally advanced NPC patients in response to intensity-modulated radiation therapy (IMRT).en
dc.language.isoen-
dc.relation.ispartofseriesEXCLI Journal;Vol. 16 2017-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.subjectNasopharyngeal carcinomaen
dc.subjectEpstein-Barr virusen
dc.subjectInduction chemotherapyen
dc.subjectIntensity-modulated radiation therapyen
dc.subjectRadiosensitivity,en
dc.subjectLogistic regressionen
dc.subject.ddc610-
dc.titleThe predictive value of pre- and post-induction chemotherapy plasma EBV DNA level and tumor volume for the radiosensitivity of locally advanced nasopharyngeal carcinomaen
dc.typeText-
dc.type.publicationtypearticle-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
eldorado.secondarypublicationtrue-
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Wang_28112017_proof.pdfDNB202.01 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons